151 related articles for article (PubMed ID: 33724301)
1. Breathe-Your immune system is counting on it.
McCarty NA
J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33724301
[TBL] [Abstract][Full Text] [Related]
2. Return-to-work, disabilities and occupational health in the age of COVID-19.
Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
[TBL] [Abstract][Full Text] [Related]
3. The early interferon catches the SARS-CoV-2.
Decker T
J Exp Med; 2021 Oct; 218(10):. PubMed ID: 34424267
[TBL] [Abstract][Full Text] [Related]
4. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
[TBL] [Abstract][Full Text] [Related]
5. Lasting memories of SARS-CoV-2 infection.
Poon MML; Farber DL
J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33739364
[TBL] [Abstract][Full Text] [Related]
6. Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection.
Kedl RM
J Exp Med; 2021 May; 218(5):. PubMed ID: 33861846
[TBL] [Abstract][Full Text] [Related]
7. An ace model for SARS-CoV-2 infection.
Major J; Wack A
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 33000129
[TBL] [Abstract][Full Text] [Related]
8. An unconventional view of COVID-19 T cell immunity.
Koay HF; Fulford TS; Godfrey DI
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 33147321
[TBL] [Abstract][Full Text] [Related]
9. Barriers to the representation of researchers from developing countries in international health and potential strategies to address these.
Haribhai S
S Afr Med J; 2021 Mar; 111(3):13228. PubMed ID: 33944733
[TBL] [Abstract][Full Text] [Related]
10. Formulation, Device, and Clinical Factors Influencing the Targeted Delivery of COVID-19 Vaccines to the Lungs.
Mossadeq S; Shah R; Shah V; Bagul M
AAPS PharmSciTech; 2022 Nov; 24(1):2. PubMed ID: 36416999
[TBL] [Abstract][Full Text] [Related]
11. mSphere of Influence: That's Racist-COVID-19, Biological Determinism, and the Limits of Hypotheses.
Taylor K
mSphere; 2020 Sep; 5(5):. PubMed ID: 33025909
[TBL] [Abstract][Full Text] [Related]
12. Not just a research method: If used with caution, can job-exposure matrices be a useful tool in the practice of occupational medicine and public health?
Fadel M; Evanoff BA; Andersen JH; d'Errico A; Dale AM; Leclerc A; Descatha A
Scand J Work Environ Health; 2020 Sep; 46(5):552-553. PubMed ID: 32367143
[TBL] [Abstract][Full Text] [Related]
13. Response to: "Managing hand trauma during the COVID-19 pandemic using a one-stop clinic" https://doi.org/10.1016/j.bjps.2020.05.026.
Redgrave N; Bray J; Burr N; Anadkat M; Haque S; Nikkhah D
J Plast Reconstr Aesthet Surg; 2021 Jul; 74(7):1633-1701. PubMed ID: 33402315
[No Abstract] [Full Text] [Related]
14. A responding to commentary: "Recognizing the role of animal-assisted therapies in addressing mental health needs during the COVID-19 pandemic" (https://doi.org/10.1016/j.ajp.2020.102390).
Wong PWC; Yu RWM; Chau KKY; Lee JCY; Ngai JTK
Asian J Psychiatr; 2021 Jul; 61():102683. PubMed ID: 33989958
[No Abstract] [Full Text] [Related]
15. Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.
Zheng C; Kar I; Chen CK; Sau C; Woodson S; Serra A; Abboud H
CNS Drugs; 2020 Sep; 34(9):879-896. PubMed ID: 32780300
[TBL] [Abstract][Full Text] [Related]
16. Immune cells-A curse and a blessing!
Mirakaj V
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 34019638
[TBL] [Abstract][Full Text] [Related]
17. Host cell-intrinsic innate immune recognition of SARS-CoV-2.
Madden EA; Diamond MS
Curr Opin Virol; 2022 Feb; 52():30-38. PubMed ID: 34814102
[TBL] [Abstract][Full Text] [Related]
18. Insights into the modulation of the interferon response and NAD
Habeichi NJ; Tannous C; Yabluchanskiy A; Altara R; Mericskay M; Booz GW; Zouein FA
Int Rev Immunol; 2022; 41(4):464-474. PubMed ID: 34378474
[TBL] [Abstract][Full Text] [Related]
19. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
Policard M; Jain S; Rego S; Dakshanamurthy S
Virus Res; 2021 Aug; 301():198464. PubMed ID: 34058265
[TBL] [Abstract][Full Text] [Related]
20. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
Nowill AE; de Campos-Lima PO
J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
